Work

Translating cancer trial endpoints into the language of managed care.

Year: 2008

Type: article

Abstract: Oncology endpoints are an essential component of cancer trials, but often they are confusing, making it difficult to evaluate cancer therapies based on trial data. As more oncology agents hit the market and as indications expand for existing products, familiarity with these endpoints is critical for payers when making coverage decisions.

Source: Europe PMC (PubMed Central)

Authors: Allan Jay Kogan, Melinda Haren

Institution: Cigna (United States)

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2420049258

FWCI:

Cites: 18

Cited by: 16

Related to: 10